Health System Executive Brings Over 20 Years’ Experience, Extensive Industry Relationships, and History of Success with Provider Groups to MedSign

New York, June 23, 2020:   MedSign International Corporation, a digital health technology company announced today that industry leader John N. Kastanis has been appointed to the company’s Senior Advisory Board, one of the industry’s strongest advisory boards for Telehealth solutions.

 Kastanis brings to the Board significant executive experience in leading high acute, tertiary, quaternary-care and specialty hospitals with core expertise in strategic planning, governance, fund development, academic medicine, while also managing large Medicaid and Medicare patient populations.

 “John is the perfect addition to our Advisory Board, and we are thrilled to have him join us in our mission in bringing Qortex to everyone”, said MedSign CEO Thomas Conroy.  “John has spent years running urban-based teaching hospitals and has seen first-hand, the digital gap faced by many poor, elderly, and minority people.  Quality and access to care have always been a part of John’s work and we are beyond grateful that he has seen the power of Qortex. We are honored to have him on the team”, Conroy added.

 Kastanis is currently a Principal Consultant at JNK Consulting and was previously President and CEO of University Hospital, Newark, NJ, where he led the state’s primary teaching hospital and clinical research site for Rutgers New Jersey Medical School. Prior to that, he served as President and CEO at Temple University Hospital, and the former Hospital for Joint Diseases Orthopedic Institute, among several others.

 “When I was introduced to MedSign and Qortex I knew right away there was tremendous potential in the technology. Having established training programs for local residents to become community health service workers, I have personally witnessed the struggles many have with learning and gaining access to new technologies”, said Kastanis. “With the easy to use Qortex system, which plugs directly into a patient's TV, you eliminate the enormous hurdle and can focus on what is most important… bringing quality care to everyone especially to those in technology averse, lower income areas and hard to reach demographics.”

Though telemedicine has not been widely used in the US prior to the COVID-19 outbreak, an eMarketer survey found that the number of US adults who reported intent to use telemedicine rose from 18% to 30% between February and March 2020.  Qortex addresses the growing need for simple, easy to use telehealth service for all and specifically for our most at-risk senior generation, by using what they already have at home and have a high degree of comfort - their TV’s. 

 The Qortex system is currently available to hospitals, physician groups, CHHAS, home-care agencies, insurers, government agencies, and others throughout California, New York, and Florida. 

For more information or interest in acquiring MedSign’s Qortex Telehealth System, call 1-800-418-9885. To learn more about Qortex visit www.medsign.com

Media Contact: Robin Sharp, robinsharp@medsign.com